Enlivex Ltd. - Ordinary Shares (NQ:ENLV)

0.8292 -0.0208 (-2.45%)

Streaming Delayed Price Updated: 9:51 AM EDT, Jun 4, 2026 Add to My Watchlist

Price and Volume

Volume	35,196
Open	0.8330
Bid (Size)	0.8290 (500)
Ask (Size)	0.8375 (900)
Prev. Close	0.8500
Today's Range	0.8292 - 0.8445
52wk Range	0.6600 - 2.100
Shares Outstanding	18,306,186
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ENLIVEX TO PRESENT QUALITY LONGEVITY MODEL POWERED BY PREDICTION MARKETS TREASURY AT PROOF OF TALK 2026

June 02, 2026

From Enlivex Ltd.

Via GlobeNewswire

Allocetra Shows Durable 6-Month Efficacy in Knee Osteoarthritis Phase IIa Trial; Oral Presentation at EULAR 2026

June 01, 2026

From Enlivex Ltd.

Via GlobeNewswire

Performance

YTD	+9.8%	+9.8%
1 Month	-2.7%	-2.7%
3 Month	-30.9%	-30.9%
6 Month	-23.9%	-23.9%
1 Year	-11.8%	-11.8%

More News

Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.16 Billion; Rain Foundation Appoints Industry Leaders to Advisory Board

May 28, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity

May 27, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

May 18, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Announces Receipt of Nasdaq Minimum Bid Price Notification

May 15, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange

April 30, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million

April 28, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress

April 23, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

April 21, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Posts $1.23B Profit (Net Income) For Fiscal 2025

March 26, 2026

Via NewMediaWire

Enlivex Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt

March 26, 2026

From Enlivex Ltd.

Via GlobeNewswire

Wondering what's happening in today's pre-market session? ↗

March 25, 2026

Via Chartmill

Enlivex Reports Full-Year 2025 Results: Profit (Net Income) of $1.23 Billion and Diluted Earnings Per Share (EPS) of $25.48

March 25, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Announces $21 Million Debt Financing, Decentralized Prediction Markets RAIN Token-Related Updates and $20 Million Share Repurchase Program

March 24, 2026

From Enlivex Ltd.

Via GlobeNewswire

Quality Longevity Company Enlivex Receives Investigational New Drug (IND) Clearance from the FDA for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

March 23, 2026

From Enlivex Ltd.

Via GlobeNewswire

Off The Hook Yachts and Enlivex Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

March 20, 2026

Via ACCESS Newswire

Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange

February 10, 2026

From Enlivex Therapeutics Ltd

Via GlobeNewswire

RedChip Fintech & DATS Conference Replays Now Available Featuring Public Companies Shaping the Future of Digital Finance

February 09, 2026

Via ACCESS Newswire

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange

January 26, 2026

From Enlivex Therapeutics Ltd

Via GlobeNewswire

Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq

January 23, 2026

From Enlivex Therapeutics Ltd

Via GlobeNewswire

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on KuCoin, a Leading Cryptocurrency Exchange

January 07, 2026

From Enlivex Therapeutics Ltd

Via GlobeNewswire

Enlivex Management to Host Fireside Chat on December 11 to Discuss RAIN Token Strategy and Allocetra Clinical Development

December 04, 2025

From Enlivex Therapeutics Ltd

Via GlobeNewswire

Enlivex Announces Closing of Previously Announced $212,000,000 Private Placement

November 26, 2025

From Enlivex Therapeutics Ltd

Via GlobeNewswire

Kartoon Studios Mainframe Studios, Toon Media, and Premium IP Pipeline Drive 2026-2027 Outlook

November 24, 2025

Via AB Newswire

Frequently Asked Questions

Is Enlivex Ltd. - Ordinary Shares publicly traded?

Yes, Enlivex Ltd. - Ordinary Shares is publicly traded.

What exchange does Enlivex Ltd. - Ordinary Shares trade on?

Enlivex Ltd. - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Enlivex Ltd. - Ordinary Shares?

The ticker symbol for Enlivex Ltd. - Ordinary Shares is ENLV on the Nasdaq Stock Market

What is the current price of Enlivex Ltd. - Ordinary Shares?

The current price of Enlivex Ltd. - Ordinary Shares is 0.8292

When was Enlivex Ltd. - Ordinary Shares last traded?

The last trade of Enlivex Ltd. - Ordinary Shares was at 06/04/26 09:51 AM ET

What is the market capitalization of Enlivex Ltd. - Ordinary Shares?

The market capitalization of Enlivex Ltd. - Ordinary Shares is 15.18M

How many shares of Enlivex Ltd. - Ordinary Shares are outstanding?

Enlivex Ltd. - Ordinary Shares has 15M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.